InvestorsHub Logo
Followers 86
Posts 3090
Boards Moderated 0
Alias Born 03/03/2010

Re: None

Thursday, 10/04/2018 11:06:41 AM

Thursday, October 04, 2018 11:06:41 AM

Post# of 5664
$HSGX pls do more dd. CEO confident of fda approval. There will not be another trial. Co. bar set intentionally high. Only 2 patients did not improve over "long term". 98% did. That's why NeoCart will get fda ok. Won't be under .70 for long, from $3.00
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OCGN News